3 Biotech Stocks You Should Be Watching

The increase of the aging population presents immense opportunities for bio-pharmaceutical companies to develop candidates to treat global ailments. Dozens of biotech stocks continue to generate significant gains for investors and as the average lifespan continues to increase, the number of drugs being developed to hit the market should follow.


The potential for share prices to skyrocket instantaneously on favorable trial news or possible FDA approval is what continues to lure investors into the space.

The NASDAQ Biotechnology Index (NBI) and the iShares NASDAQ Biotech EFT (IBB) are both up about 12 percent over the last trailing year, while the SPDR S&P Biotech ETF (XBI) is showing gains over 20 percent. As the sector continues to heat up, here are 3 bio-pharmaceutical companies that could have potential in their pipelines.


Click Here To See 3 Biotech Stocks With Potential In Their Pipelines.



Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s